Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

E-GEOD-57488

ABSTRACT: RNA-sequencing analysis of glucose and acetate regulated transcripts in glioblastoma cells

OTHER RELATED OMICS DATASETS IN: PRJNA246544

PROVIDER: E-GEOD-57488 | ExpressionAtlas | 2025-01-24

REPOSITORIES: ExpressionAtlas

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	E-GEOD-57488-analysis-methods.tsv	Tabular
	E-GEOD-57488-analytics.tsv	Tabular
	E-GEOD-57488-analytics.tsv.undecorated	Tabular
	E-GEOD-57488-analytics.tsv.undecorated.unrounded	Tabular
	E-GEOD-57488-analytics.tsv.unrounded	Tabular

Items per page:

1 - 5 of 34

Similar Datasets

Homo sapiens

Project description:RNA-sequencing analysis of glucose and acetate regulated transcripts in glioblastoma cells

| PRJNA246544 | ENA

Identification of the molecular basis of anti-cancer effect of Huaier.

Project description:Intervention type:DRUG. Intervention1:Huaier, Dose form:GRANULES, Route of administration:ORAL, intended dose regimen:20 to 60/day by either bulk or split for 3 months to extended term if necessary. Control intervention1:None. Primary outcome(s): For mRNA libraries, focus on mRNA studies. Data analysis includes sequencing data processing and basic sequencing data quality control, prediction of new transcripts, differential expression analysis of genes. Gene Ontology (GO) and the KEGG pathway database are used for annotation and enrichment analysis of up-regulated genes and down-regulated genes. For small RNA libraries, data analysis includes sequencing data process and sequencing data process QC, small RNA distribution across the genome, rRNA, tRNA, alignment with snRNA and snoRNA, construction of known miRNA expression pattern, prediction New miRNA and Study of their secondary structure Based on the expression pattern of miRNA, we perform not only GO / KEGG annotation and enrichment, but also different expression analysis.. Timepoint:RNA sequencing of 240 blood samples of 80 cases and its analysis, scheduled from June 30, 2022..

| 2612481 | ecrin-mdr-crc

Identification of the molecular basis of anti-cancer effect of Huaier.

Project description:Intervention type:DRUG Name of intervention:Huaier Dose form / Japanese Medical Device Nomenclature:GRANULES Route of administration / Site of application:ORAL Dose per administration:20? g Dosing frequency / Frequency of use:OTHER, SPECIFY 20g? per day Planned duration of intervention:3 months to extending if necessary Intended dose regimen:20 to 60/day by either bulk or split for 3 months to extended term if necessary detailes of teratment arms:hepatocellular carcinoma, breast cancer, colorectal cancer and related gastrointestinal cancers, urologic cancers including prostate cancer, pancreas cancer, and lung cancer, etc. Comparative intervention name:None Dose form / Japanese Medical Device Nomenclature: Route of administration / Site of application: Dose per administration: Dosing frequency / Frequency of use: Planned duration of intervention: Intended dose regimen: Primary outcome(s): For mRNA libraries, focus on mRNA studies. Data analysis includes sequencing data processing and basic sequencing data quality control, prediction of new transcripts, differential expression analysis of genes. Gene Ontology (GO) and the KEGG pathway database are used for annotation and enrichment analysis of up-regulated genes and down-regulated genes. For small RNA libraries, data analysis includes sequencing data process and sequencing data process QC, small RNA distribution across the genome, rRNA, tRNA, alignment with snRNA and snoRNA, construction of known miRNA expression pattern, prediction New miRNA and Study of their secondary structure Based on the expression pattern of miRNA, we perform not only GO / KEGG annotation and enrichment, but also different expression analysis. Study Design: Comparative test, None, No, open(masking not used), EXPLORATORY

| 98681 | ecrin-mdr-crc

E-GEOD-59612

Project description:Transcription profiling by high throughput sequencing in the margins of glioblastoma

2025-01-24 | E-GEOD-59612 | ExpressionAtlas

E-GEOD-73175

Project description:RNA sequencing of primary thymic, bone and skin mesenchymal cells

2016-05-13 | E-GEOD-73175 | ExpressionAtlas

E-GEOD-66301

Project description:Gene expression profiling of patient's DCIS-IDC tandem lesions by RNA sequencing analysis

2025-01-24 | E-GEOD-66301 | ExpressionAtlas

E-MTAB-6991

Project description:RNA-seq analysis of PROX1 overexpression and knockdown in glioblastoma cell lines

2025-01-23 | E-MTAB-6991 | ExpressionAtlas

E-GEOD-46490

Project description:High-throughput RNA sequencing of human preovulatory cumulus and mural granulosa cells (mRNA)

2025-01-24 | E-GEOD-46490 | ExpressionAtlas

E-GEOD-59831

Project description:Transcriptome analysis of isolated stormal cells and tumor epithelial cells in mouse lung cancer by RNA-Seq

2019-05-14 | E-GEOD-59831 | ExpressionAtlas

E-GEOD-97324

Project description:RNA-seq analysis of MCT8-deficient and healthy control brain microvascular endothelial cells (BMECs) and neural cells

2024-04-19 | E-GEOD-97324 | ExpressionAtlas

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data